Search…

Xingqi Eye Medicine (300573.SZ): SQ-25012 Injection Receives Clinical Trial Approval Notice

15/09/2026

Zhitong Finance APP news, Xingqi Eye Medicine (300573.SZ) announced that recently, the company received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration regarding SQ-25012 injection, agreeing to conduct clinical trials of this product for the proposed treatment of thyroid eye disease.

Latest

2 m ago

Elon Musk talks about artificial intelligence: If AI can take over military systems, such as launching nuclear missiles... the consequences would be unimaginable.

2 m ago

Hong Kong stocks close: Hang Seng Index down 1.00%, Hang Seng Tech Index down 0.62%

3 m ago

Peng Group's first global X-Energy megawatt flash charging station has officially landed in Hong Kong and commenced operation.

3 m ago

XPeng Motors: Today, XPeng Group's first global X-Energy megawatt ultra-fast charging station officially landed in Hong Kong and began operation. The station was jointly built by XPeng Group and Halo, and is open to owners of all brands. This is not only Hong Kong's first megawatt ultra-fast charging station open to the public, but also another milestone for XPeng's self-developed energy replenishment technology.

3 m ago

Report shows: China's catering industry demonstrates resilience in its development.

See all latest